Genetic heterogeneity of disorders with overgrowth and intellectual disability: Experience from a center in North India
- PMID: 33942996
- DOI: 10.1002/ajmg.a.62241
Genetic heterogeneity of disorders with overgrowth and intellectual disability: Experience from a center in North India
Abstract
Overgrowth, defined as height and/or OFC ≥ +2SD, characterizes a subset of patients with syndromic intellectual disability (ID). Many of the disorders with overgrowth and ID (OGID) are rare and the full phenotypic and genotypic spectra have not been unraveled. This study was undertaken to characterize the phenotypic and genotypic profile of patients with OGID. Patients with OGID were ascertained from the cohort of patients who underwent cytogenetic microarray (CMA) and/or exome sequencing (ES) at our center over a period of 6 years. Thirty-one subjects (six females) formed the study group with ages between 3.5 months and 13 years. CMA identified pathogenic deletions in two patients. In another 11 patients, a disease causing variant was detected by ES. The spectrum of disorders encompassed aberrations in genes involved in the two main pathways associated with OGID. These were genes involved in epigenetic regulation like NSD1, NFIX, FOXP1, and those in the PI3K-AKT pathway like PTEN, AKT3, TSC2, PPP2R5D. Five novel pathogenic variants were added by this study. NSD1-related Sotos syndrome was the most common disorder, seen in five patients. A causative variant was identified in 61.5% of patients who underwent only ES compared to the low yield of 11.1% in the CMA group. The molecular etiology could be confirmed in 13 subjects with OGID giving a diagnostic yield of 42%. The major burden was formed by autosomal dominant monogenic disorders. Hence, ES maybe a better first-tier genomic test rather than CMA in OGID.
Keywords: Sotos syndrome; developmental delay; exome sequencing; macrocephaly; overgrowth.
© 2021 Wiley Periodicals LLC.
References
REFERENCES
-
- Anazi, S., Maddirevula, S., Faqeih, E., Alsedairy, H., Alzahrani, F., Shamseldin, H. E., Patel, N., Hashem, M., Ibrahim, N., Abdulwahab, F., Ewida, N., Alsaif, H. S., al sharif, H., Alamoudi, W., Kentab, A., Bashiri, F. A., Alnaser, M., AlWadei, A. H., Alfadhel, M., … Alkuraya, F. S. (2017). Clinical genomics expands the morbid genome of intellectual disability and offers a high diagnostic yield. Molecular Psychiatry, 22(4), 615-624. https://doi.org/10.1038/mp.2016.113
-
- Baujat, G., Rio, M., Rossignol, S., Sanlaville, D., Lyonnet, S., Le Merrer, M., Munnich, A., Gicquel, C., Colleaux, L., & Cormier-Daire, V. (2005). Clinical and molecular overlap in overgrowth syndromes. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 137C(1), 4-11. https://doi.org/10.1002/ajmg.c.30060
-
- Bellucco, F. T., de Mello, C. B., Meloni, V. A., & Melaragno, M. I. (2019). Malan syndrome in a patient with 19p13.2p13.12 deletion encompassing NFIX and CACNA1A genes: Case report and review of the literature. Molecular Genetics & Genomic Medicine, 7(12), e997. https://doi.org/10.1002/mgg3.997
-
- Burkardt, D. D., Tatton-Brown, K., Dobyns, W., & Graham, J. M., Jr. (2019). Approach to overgrowth syndromes in the genome era. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 181C(4), 483-490. https://doi.org/10.1002/ajmg.c.31757
-
- Cohen, M. M., Neri, G., & Weksberg, R. (2002). Overgrowth syndromes. Oxford Monographs on Medical Genetics . Oxford University Press.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials